Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Smoltek starts an IR blog for in-depth information on the company's news

This press release is an English version of the previously published Swedish version, which has interpretive precedence. Smoltek Nanotech Holding AB (“Smoltek”) announces that the company, with the aim of strengthening communication with shareholders and investors, has started an IR blog where the company's press-releases and other news receive in-depth explanations.“I believe that shareholders and investors appreciate getting more detailed information about the tremendous business opportunities that we are about to realize. With the newly started IR blog, we want to show the

October 25th marks the publication of a compelling memoir of courage: THE CHINA FREEDOM TRAP: MY LIFE ON THE RUN by Dolkun Isa, President of the World Uyghur Congress and Nobel Peace Prize nominee.

The remarkable story of one man’s fight for the Uyghur people, his people, against the largest government on the planet, and a warning to the world.Dolkun Isa’s life is a story of unflinching courage - from his activist student days in East Turkestan to the harrowing accusation of being labelled a murderer and terrorist by the Chinese Communist Party, including an Interpol Red Notice. This is not just a memoir; it’s a testament to resilience, hope, and undying spirit. Every page unveils the heartbreaking tales of the Uyghur genocide in Jinjiang, captivating readers with Dolkun’s

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 171 - 17 OCTOBER 2023 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 112/23 and 113/23.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

BioStock: Respiratorius secures additional patent

Respiratorius has secured its second patent for the drug candidate VAL001, a new oral formulation of sodium valproate for the treatment of cancer. The company thus adds another important piece to the puzzle that will strengthen the project in the ongoing partnering, where discussions are currently underway with potential takers.Read the full article at biostock.se : https://www.biostock.se/en/2023/10/respiratorius-secures-additional-patent/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Nightingale Health Plc – Managers’ transactions – Ilkka Laurila

Managers' Transactions, 17 October 2023 at 10.15 a.m. (EEST) ____________________________________________  Person subject to the notification requirement  Name: Ilkka Laurila  Position: Member of the Board/Deputy member  Issuer: Nightingale Health Oyj  LEI: 743700WUIPC24LVMLO66  Notification type: INITIAL NOTIFICATION  Reference number: 40784/5/4  ____________________________________________  Transaction date: 2023-10-12  Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)  Instrument type: SHARE  ISIN: FI4000490875  Nature of transaction: ACQUISITION

Risk Intelligence A/S welcomes Teekay Tankers, to the Risk Intelligence System and operational intelligence support

Risk Intelligence A/S (“Risk Intelligence” or "the Company") has signed an agreement with Teekay Tankers, providing access to the Risk Intelligence System as well as operational intelligence consultancy.Teekay was founded in 1973 by Torben Karlshoej, hence, his initials inspired the company name, Teekay. Under his leadership, the company evolved into one of the most prestigious ship owners and marine operators. Teekay’s tanker operations are managed out of Singapore, where they will have direct access to the support of the Risk Intelligence Singapore Office and Analysts.   The Risk

Fiskars Corporation to publish its Interim Report for January-September 2023 on October 26, 2023

Fiskars CorporationPress ReleaseOctober 17, 2023 at 10:00 a.m. EEST Fiskars Corporation to publish its Interim Report for January-September 2023 on October 26, 2023 Fiskars Corporation will publish its Interim Report for January-September 2023 on October 26, 2023 at approximately 8:30 a.m. (EEST). The Interim Report will be available on the company's website www.fiskarsgroup.com after publication. Webcast A webcast on the third quarter results will be held on October 26, 2023 at 14:00 p.m. (EEST). It will be held in English and can be followed at https://fiskars.videosync.fi/

EPO and EUIPO announcement: Owning Intellectual Property (IP) rights boosts startups’ ability to raise funds

The European Patent Office (EPO) and the European Union Intellectual Property Office (EUIPO) published on 17 October 2023 a joint study highlighting how much patents and trademarks can boost the success of European startups. The report shows that, on average, startups that possess these two types of intellectual property (IP) rights during their initial seed or early growth stages are up to 10 times more likely to successfully secure funding.Munich, 17 October 2023 – Today, the European Patent Office (EPO) and the European Union Intellectual Property Office (EUIPO) have published a new

Loomis AB to publish Interim report on October 26, 2023

Loomis AB will publish the Interim report January-September 2023 on Thursday October 26, at 8:00 a.m. (CEST).Agenda   8.00 a.m. (CEST) - Report release The report will be sent as a press release from Cision (www.cision.se) and will automatically be published on www.loomis.com when released.   8:30 a.m. (CEST) - Presentation slides available For presentation slides, go to www.loomis.com and choose “Financial presentation”.   9.00 a.m. (CEST) – Telephone conference and audio cast Analysts and media are invited to participate in a telephone conference at 9:00 a.m.

SKF confirms closure of Luton factory

Gothenburg, 17 October 2023: Following a consultation process with employees and union representatives, SKF confirms the proposed closure of its factory in Luton, UK. The proposal was made in May 2023 as part of a consolidation of the Group’s spherical roller bearing manufacturing to secure the long-term competitiveness on the European markets. The Luton factory employs approximately 300 people and will be closed for production by the end of 2024 in a staged process. David Johansson, President, Industrial Region Europe Middle East and Africa, says: “Following a comprehensive

Resand supports the green transition in the foundry industry by providing Suomivalimo with a sand regeneration and recycling service

Resand Oy           Press release       17 October 2023 at 10:00 a.m. EESTResand Oy, a specialist in environmentally friendly sand regeneration technology, has signed a service agreement with the iron casting supplier Suomivalimo, a company based in Iisalmi, Finland. Under the agreement, Resand will recycle and regenerate the waste sand from Suomivalimo’s casting process for reuse. In cooperation with Resand, the recycling rate of Suomivalimo's sand usage will increase significantly and the amount of waste sand will be reduced. Suomivalimo, which uses furan resin technology, supplies its

UPM selects Dongsung Chemical as sole Korean distributor of its new bio-based MEG

dongsungchemical_CI [Logo Dongsung Chemical] Logo Dongsung Chemical (UPM, Helsinki, 17 October at 10:00 EEST) – UPM Biochemicals  has selected Dongsung Chemical  as sole distributor of its bio-monoethylene glycol (BioMEG) UPM BioPura™ in Korea. This further strengthens the development partnership between the two companies that was announced last year. By adding UPM to its supplier network, Dongsung enhances the sustainability transformation of its portfolio and supports the evolution of the chemical industry in Korea

Invitation to UPM’s webcast and press conference on Q3 2023 Interim report

(UPM, Helsinki, 17 October 2023 at 10:00 EEST) – UPM will publish its Q3 2023 results on Tuesday, 24 October 2023 at 09:30–10:00 EEST. After publishing, the report will be available on the company website at www.upm.com . A webcast and a conference call for analysts and investors in English begins at 13:15 EEST. The interim report will be presented by the President and CEO Jussi Pesonen and CFO Tapio Korpeinen. Participants can view the webcast online through this link , but those who wish to ask questions from the

Diamyd Medical announces a webcast presentation on October 20 regarding its industry partnership with JDRF

Diamyd Medical is hosting a webcast presentation on October 20th at 2:00 pm CET / 8:00 am EDT with Ulf Hannelius, CEO of Diamyd Medical, Josh Vieth, Director of Research at JDRF, as well as Mark Atkinson, Director for the University of Florida Diabetes Institute and member of the Board of Directors of Diamyd Medical. The webcast will review the industry partnership between Diamyd Medical and JDRF announced in April of this year, discuss the current state of immunomodulatory approaches in Type 1 Diabetes and most notatably, the antigen-specific immunotherapy Diamyd[®] that is currently

Moberg Pharma’s Nomination Committee appointed

STOCKHOLM, October 17[th], 2023 – In accordance with the resolution of the Annual General Meeting on May 16[th], 2023, the Chairman of the Board has contacted the company’s two largest shareholders or group of shareholders in terms of votes to form a Nomination Committee. These shareholders have been invited to appoint one representative each who, together with the Chairman of the Board, will comprise the Nomination Committee. As not all of the company’s two largest shareholders or group of shareholders have wished to appoint such representative, the third largest shareholder/group of

Invitation to web presentation of Formpipe’s Q3 report 2023.

Formpipe will publish its interim report for the third quarter 2023 on Wednesday 25 October 2023 at 08:15 (CEST).The same day at 10:00 (CEST), Formpipe’s President and CEO Magnus Svenningson will host a web presentation in English which is webcasted live on: http://www.formpipe.com/en/q32023, where it also will be available on demand shortly afterwards. Following the presentation, Magnus Svenningson, and Joakim Alfredson CFO, will be available to answer questions. The report and presentation will be available at: www.formpipe.com/en/investors/reports-and-presentations Welcome!

Wyld Networks fulfils obligations to European Space Agency (ESA) to develop satellite-to-satellite connectivity with Eutelsat and Thales

Wyld Networks have delivered the LoRaWAN satellite-to-satellite connectivity solution as part of a joint ESA-sponsored programme with Eutelsat and Thales for telemetry and control to support satellite IoT networks. Wyld have used LoRa CSS and LoRa FHSS protocols to establish bi-directional communication with satellites and ground stations. As part of the program, Wyld’s IoT module is being built into low earth orbiting satellites to provide radio connectivity. Wyld have now delivered this technology to the programme. Satellite-to-satellite connectivity will not only improve command

Members of the Nomination Committee for Episurf Medical’s Annual General Meeting in 2024

In accordance with the decision by the Annual General Meeting, Episurf Medical’s Nomination Committee shall consist of four members. The members are selected by the three largest shareholders in the company that wish to participate in the committee. In addition, the Chairman of the Board is to be appointed to the Nomination Committee. The members of the Nomination Committee shall agree on a chairman/woman of the committee. In accordance with the above principles, the Nomination Committee consists of the following four members: · Ulf Grunander, styrelseordförande i Episurf Medical AB

HANZA presents interim report November 7

HANZA will publish its interim report for the third quarter of 2023 on November 7 at 8.00 am CET. In connection with the report, HANZA invites investors, analysts and media to a combined conference call and audiocast at 11.00 am CET the same day.The report will be presented by CEO Erik Stenfors and CFO Lars Åkerblom. The presentation will be held in English. Time: Tuesday, November 7 at 11:00 a.m. Participate via webcast: https://financialhearings.com/event/46046 Participate via teleconference: Register via this link to 

Catena Media announces share buybacks executed from 9 to 13 October 2023

Catena Media plc (LEI code: 549300609A73DL5C5Z86) repurchased 75,000 of its own ordinary shares (ISIN code: MT0001000109) from 9 to 13 October 2023 as part of its share buyback programme. The buyback programme was authorised by shareholders at an extraordinary general meeting on 12 July 2023 and initiated and announced by the board of directors on 17 July 2023. The programme is being carried out in accordance with the EU Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU) 2016/1052 (the "Safe Harbour Regulation"). Its purpose is to deliver

Ratos Company Semcon spins off its Product Information business area, introduces Aleido

Semcon announces the successful spinoff of its Product Information business area, marking the official launch of new and stand-alone company Aleido. This strategic step has been taken to strengthen both businesses and to continue growing their offers, dedicated teams, and profitability.The Product Information business area, with its 850 employees in five countries, is known for its expertise in creating user-friendly digital aftermarket solutions for complex products. As a global leader, it serves customers such as Volvo Cars, Tetra Pak, Alstom, AGCO, Jaguar Land Rover and Epiroc.“At

Eevia Health Plc received a 168 kSEK / 15 kEUR order for a rapeseed extract.

Eevia Health Plc, (”Eevia” or ”The Company”), has received a sales order from a Finnish food company for a custom made rapeseed extract for the value of 15 kEUR (168 kSEK).The customer is a large food ingredient manufacturer, and a significant producer of vegetable and rapeseed oils. Their main markets for are Finland and the other Nordic countries. Eevia will fulfill this order by extracting a custom-made rapeseed extract based. The order is based an exclusive frame agreement for this product. The order is expected to create repeat sales of this product going forward. For further

INVITATION: Finnair Q3 2023 result – Press conference / webcast and analyst webcast

Finnair will hold a Q3 2023 results press conference (in Finnish) on 24 October 2023 at 12.00 p.m. EEST at its office at Tietotie 9, Vantaa. It is also possible to participate in the press conference via a live webcast at https://finnairgroup.videosync.fi/2023-10-24-press.    An English-language telephone conference and webcast will be held on 24 October 2023 at 3.00 p.m. EEST. To access the conference, kindly first register at https://palvelu.flik.fi/teleconference/?id=10010297. After the registration, you will be provided with phone numbers and a conference ID. We kindly suggest

Invitation to conference call with web presentation of Cloetta AB´s interim report Q3 2023

Cloetta AB will publish the interim report for the period 1 July – 30 September 2023 on Friday 27 October 2023 at 7.30 a.m. CEST. Following this report Cloetta will organise a conference call with web presentation for media and the financial community.President and CEO Henri de Sauvage Nolting and CFO Frans Rydén will present and comment on the report. After the presentation there will be time for questions, both on the phone and in the web presentation.   Time for the publication of the interim report Friday 27 October at 07:30 a.m. CEST    Time for conference call and web

There are no items matching the current filter
There are no more items matching the current filter
Back to top